[Transluminal coronary angioplasty using a percutaneous axillary route with an arterial sheath].
Out of 1400 percutaneous transluminal coronary angioplasties (PTCA), 23 (1.6 p. 100) were performed by the left percutaneous axillary approach because the bifemoral approach could not be used. There were 18 patients (17 men, 1 woman) with a mean age of 58 years. The coronary vessels dilated were the anterior interventricular artery (n = 4), the circumflex artery (n = 9) and the right coronary artery (n = 10), i.e. a total of 25 stenoses. The success rate in procedures was 83 p. 100 (19/23), and the primary success rate in patients was 83.3 p. 100 (15/18): Despite a good initial result, one patient developed inferior myocardial infarction as a result occlusion of a dominant distal circumflex artery, due to protamine administration immediately after the procedure. Another failure ascribable to the approach was due to selective catheterization being impossible. The mean duration of TCA was 38 min. In every cases the arterial introducer was withdrawn after neutralization with protamine. There were 4 cases of restenosis (25 p. 100) :3 were treated by a second PTCA using the percutaneous axillary approach and 1 by surgery. The method has the following disadvantages: (1) neutralization with protamine is mandatory (we had 1 case of occlusion with infarction after protamine in this series); (2) it is imperative to prevent the formation of a blood collection that would infiltrate the brachial plexus; for this purpose, the axillary cavity must be compressed effectively after PTCA and the puncture area must be watched for 24 to 48 hours.(ABSTRACT TRUNCATED AT 250 WORDS)
Valeix
B
B
Unité cardio vasculaire, Goélette, Marseille.
Labrunie
P
P
Boyer
C
C
Escojido
H
H
Nebunu
J C
JC
D000328:Adult; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D003327:Coronary Disease / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011479:Protamines / Q000627:therapeutic use; D013997:Time Factors
D011479:Protamines
Angioplastie coronaire transluminale par voie percutanée axillaire avec introducteur artériel.